Biotage AB (publ) (LON:0GRP)

Market Cap	887.83M
Revenue (ttm)	151.21M
Net Income (ttm)	19.66M
Shares Out	n/a
EPS (ttm)	0.25
PE Ratio	45.15
Forward PE	59.66
Dividend	0.13 (0.09%)
Ex-Dividend Date	Apr 25, 2025

Volume	759
Average Volume	1,592
Open	142.90
Previous Close	142.70
Day's Range	142.90 - 143.10
52-Week Range	83.25 - 201.40
Beta	0.85
RSI	60.98
Earnings Date	Aug 6, 2025

About Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, parallel peptide purification, and work-up products; flash systems and accessories, and normal and reversed phase cartridges; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal and supported scavengers and reagents, as well as accessories and spare parts...

• Industry: Laboratory Analytical Instruments
• Founded: 1969
• Employees: 680
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0GRP

Financial Performance

In 2024, Biotage AB's revenue was 2.06 billion, an increase of 10.42% compared to the previous year's 1.86 billion. Earnings were 284.00 million, an increase of 15.45%.

Financial numbers in SEK